Transforming growth factor-β3 expression up-regulates on cleft palates induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin in mice

Toxicology and Industrial Health

Volumn 25, Issue 7, 2009, Pages 473-478

  Gan, Li Qiang ^a   Fu, Yue Xian ^a   Liu, Xing ^a   Qiu, Lin ^a   Wu, Sheng De ^a   Tian, Xiao Fei ^a   Liu, Yan ^a   Wei, Guang Hui ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

2,3,7,8 Tetrachlorodibenzo p dioxin; cleft palate; mouse; transforming growth factor 3

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; CORN OIL; TRANSFORMING GROWTH FACTOR BETA3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CLEFT PALATE; CONTROLLED STUDY; FEMALE; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING;

ABNORMALITIES, DRUG-INDUCED; ANALYSIS OF VARIANCE; ANIMALS; BLOTTING, WESTERN; CLEFT PALATE; FEMALE; FETUS; IMMUNOHISTOCHEMISTRY; MICE; PREGNANCY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TETRACHLORODIBENZODIOXIN; TRANSFORMING GROWTH FACTOR BETA3; UP-REGULATION;

MUS; ZEA MAYS;

EID: 70349518912     PISSN: 07482337     EISSN: None     Source Type: Journal    
DOI: 10.1177/0748233709345940     Document Type: Article

References (24)

1. Abbott BD and Birnbaum LS (1989a) TCDD alters medial epithelial cell differentiation during palatogenesis. Toxicology and Applied Pharmacology 99: 276-286.
2. Abbott BD and Birnbaum LS (1989b) Cellular alterations and enhanced induction of cleft palate after coadministration of retinoic acid and TCDD. Toxicology and Applied Pharmacology 99: 287-301.
3. Abbott BD and Birnbaum LS, and Pratt RM (1987) TCDDinduced hyperplasia of the ureteral epithelium produces hydronephrosis in murine fetuses. Teratology 35: 329-334.
4. Ahmed S., Liu CC, and Nawshad A. (2007) Mechanisms of palatal epithelial seam disintegration by transforming growth factor (TGF) beta3. Developmental Biology 309: 193-207.
5. Britto JA, Evans RD, Hayward RD, and Jones BM (2002) Toward pathogenesis of Apert cleft palate: FGF, FGFR, and TGF beta genes are differentially expressed in sequential stages of human palatal shelf fusion. The Cleft Palate-Craniofacial Journal 39: 332-340.
6. Cuervo Rodrigo, Valencia Concepción, Roshantha AS, et al. (2002) Programmed cell death is required for palate shelf fusion and is regulated by retinoic acid and luis. Covarrubias Developmental Biology 245: 145-156.
7. Cuervo Rodrigo and Covarrubias Luis (2004) Death is the major fate of medial edge epithelial cells and the cause of basal lamina degradation during palatogenesis. Development 131: 15-24.
8. Dolinoy DC and Jirtle RL (2008) Environmental epigenomics in human health and disease. Environmental and Molecular Mutagenesis 49: 4-8.
9. Fujiwara K., Yamada T., Mishima K., Imura H., and Sugahara T. (2008) Morphological and immunohistochemical studies on cleft palates induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin in mice. Congenital Anomalies 48: 68-73.
10. Jin JZ and Ding J. (2006) Analysis of cell migration, trans-differentiation and apoptosis during mouse secondary palate fusion. Development 133: 3341-3347.
11. Manabe T., Tatsumi K., Inoue M., et al. (2007) L3/Lhx8 is a pivotal factor for cholinergic differentiation of murine embryonic stem cells. Cell Death and Differentiation, 14: 1080-1085.
12. Martinez-Alvernia EA, Rudnick JA, and Mankarious LA (2008) Transforming growth factor beta3 increases chondrocyte proliferation and decreases apoptosis in murine cricoid cartilage in vitro. Otolaryngology-Head and Neck Surgery 138: 435-440.
13. McConnell EE and Moore JA (1979) Toxicopathology characteristics of the halogenated aromatics. Annals of the New York Academy of Sciences 320: 138-150.
14. Memon MA, Anway MD, Covert TR, Uzumcu M., and Skinner MK (2008) Transforming growth factor beta (TGFbeta1, TGFbeta2 and TGFbeta3) null-mutant phenotypes in embryonic gonadal development. Molecular and Cellular Endocrinology 294: 70-80.
15. Moore JA, McConnell EE, Dalgard DW, and Harris MW (1979) Comparative toxicity of three halogenated dibenzofurans in guinea pigs, mice, and rhesus monkeys. Annals of the New York Academy of Sciences 320: 151-163.
16. Kayano S., Suzuki Y., Kanno K., et al. (2004) Significant association between nonsyndromic oral clefts and arylhydrocarbon receptor nuclear translocator (ARNT) American Journal of Medical Genetics A 130A: 40-44.
17. Kohama K., Nonaka K., Hosokawa R., Shum L., and Ohishi M. (2002) TGF-beta-3 promotes scarless repair of cleft lip in mouse fetuses. Journal of Dental Research 81: 688-694.
18. Nogai H., Rosowski M., Grün J., et al. (2008) Follistatin antagonizes transforming growth factor-beta3-induced epithelial-mesenchymal transition in vitro: implications for murine palatal development supported by microarray analysis. Differentiation 76: 404-416.
19. Olasoji HO, Ukiri OE, and Yahaya A. (2005) Incidence and aetiology of oral clefts: a review. African Journal of Medicine and Medical Sciences 34: 1-7.
20. Taya Y., O'Kane S., and Ferguson MW (1999) Pathogenesis of cleft palate in TGF-b3 knockout mice. Development 126: 3869-3879.
21. Thomae TL, Stevens EA, and Bradfield CA (2005) Transforming growth factor-β3 restores fusion in palatal shelves exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. The Journal of Biological Chemistry 280: 12742-12746.
22. Vorderstrasse BA, Fenton SE, Bohn AA, Cundiff JA, and Lawrence BP (2004) A novel effect of dioxin: exposure during pregnancy severely impairs mammary gland differentiation. Toxicological Sciences 78: 248-257.
23. Willingham E. and Baskin LS (2007) Candidate genes and their response to environmental agents in the etiology of cleft palate. Nature Clinical Practice Urology 4: 270-279.
24. Yamada T., Mishima K., Fujiwara K., Imura H., and Sugahara T. (2006) Cleft lip and palate in mice treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin: a morphological in vivo study. Congenital Anomalies 46: 21-25.